I'd like to congratulate the authors on their achievement with this publication. This will open up a whole new world of treatment paradigms for patients that present outside the original "thrombolysis window". I had one question that I'd like to ask.
In clinical practice, from my experience, if a patient presents outside the thrombolysis window (> 4.5 hours), in most cases, an anti-platelet (such as aspirin) is commenced. This study compared alteplase with placebo; do you think the results would be reproducible if alteplase was compared with perhaps aspirin or another anti-platelet?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.